Literature DB >> 2992109

Breast cancer in a patient with prolactinoma.

S P Theodorakis, V E Tedesco, C M Sutherland.   

Abstract

Although the role of prolactin in the initiation and promotion of mammary carcinoma has been proved in animal experiments, a similar effect of hormone in the development of human mammary tumor has not been clearly demonstrated. If hyperprolactinemia is a significant factor in the initiation and promotion of human breast carcinoma, the incidence of mammary carcinoma in patients with hyperprolactinemia, with or without prolactinomas, might be higher than in control populations, but this relationship has never been documented. We present this case to stimulate awareness of the possibility so the condition will be investigated further.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992109

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

Review 1.  A rare case of male breast ductal carcinoma in-situ associated with prolactinoma.

Authors:  Chandike Maithri Mallawaarachchi; Snezana Ivanova; Alice Shorthouse; Sami Shousha; Dudley Sinnett
Journal:  BMJ Case Rep       Date:  2011-08-31

Review 2.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

3.  The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture.

Authors:  E Jimenez-Hakim; M el-Azouzi; P M Black
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

4.  Breast cancer in a male patient with prolactinoma.

Authors:  S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 5.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.